Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical ...
Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical ...
Stay updated with breaking news from Christopher Nardo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical ...
- About 550 patients will be treated once weekly for 12 weeks -- STAR-1 topline results expected in first quarter of 2025 -- Acne affects about 50 million patients in the U.S. -SAN DIEGO, CA / ACCESSWIRE / December 20, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company&q...
OTC Direct Connect will improve data access for OTC derivatives trades reported to DTCC’s Data Repository, using AWS Data Exchange to reference trade data held in AWS cloud
See results of school district budget, board member and proposition votes for the coming school year.